Emergent BioSolutions Inc (NYSE:EBS)
| 8.21 Delayed Data As of Jun 02 |  +0.01 / +0.12%Today’s Change | 7.74 Today|||52-Week Range 36.14 | -30.48% Year-to-Date |
Latest EBS News | Press Releases
No recent news for Emergent BioSolutions Inc.
Today’s Trading
| Previous close | 8.20 |
| Today’s open | 8.35 |
| Day’s range | 8.16 - 8.45 |
| Volume | 1,028,298 |
| Average volume (3 months) | 1,589,163 |
| Market cap | $411.7M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -203.50% |
| Earnings growth (this year) | +32.47% |
| Earnings growth (next 5 years) | +34.00% |
| Revenue growth (last year) | -37.47% |
| P/E ratio | NM |
| Price/Sales | 0.53 |
| Price/Book | 0.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CHRSCoherus BioSciences ... | +0.39 | +9.63% |
| OTLKOutlook Therapeutics... | -0.03 | -1.84% |
| KODKodiak Sciences Inc | +1.50 | +23.62% |
| SIGASIGA Technologies In... | +0.13 | +2.28% |
Data as of 4:00pm ET, 06/02/2023
Financials
| Next reporting date | July 27, 2023 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$223.8M |
| Net profit margin | -19.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
